Physician profile
Peter Gergely
NPI 1619051117
$303.99
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $32.69 · 2021: $16.16 · 2022: $95.39.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $86.43 | 2019-2022 | |
| Adlon Therapeutics L.P. | $44.80 | 2019-2020 | |
| Sobi, INC | $40.81 | 2019 | |
| Ironshore Pharmaceuticals INC. | $39.78 | 2019 | |
| Pfizer INC. | $31.25 | 2019 | |
| Corium, LLC | $23.96 | 2022 | |
| Shire North American Group INC | $20.80 | 2019 | |
| Merck Sharp & Dohme LLC | $16.16 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Gergely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.